Hello Ash,
When you refer to "estrogen levels", are you referring to E2 levels or total estrogens? Total estrogens are reported as E1 (estrone), E2 (estradiol), and E3 (estriol) levels, although the latter is typically very low except in pregnant women. The reason I ask is I recently had a blood assay that reported only total estrogens, and it was over 1000 pg/mL, which was way higher than I expected (I take my estradiol sublingually and usually get an E2 level of 150-200 pg/mL). A subsequent blood draw reported my E2 levels as 70 pg/mL and E1 levels about ten times higher.
Most clinicians use average luteal phase concentrations of E2 for cis-women as a target (100-250 pg/mL). Your serum levels seem to be much higher, but that is very dependent on when your blood draws are taken in relation to your injections.
That said, peak plasma estrogen levels are probably not a good index of bioavailability due to the pharmacokinetics of estrogen metabolism (see reference below). A better clinical picture of estradiol levels is the AUC (Area Under the Curve) which is a function of plasma levels over time.
CLIMACTERIC 2005;8(Suppl 1):3–63
H. Kuhl, Department of Obstetrics and Gynecology, J. W. Goethe University of Frankfurt, Germany
ABSTRACT
This review comprises the pharmacokinetics and pharmacodynamics of natural and synthetic estrogens and progestogens used in contraception and therapy, with special consideration of hormone replacement therapy. The paper describes the mechanisms of action, the relation between structure and hormonal activity, differences in hormonal pattern and potency, peculiarities in the properties of certain steroids, tissue specific effects, and the metabolism of the available estrogens and progestogens. The influence of the route of administration on pharmacokinetics, hormonal activity and metabolism is presented, and the effects of oral and transdermal treatment with estrogens on tissues,
clinical and serum parameters are compared. The effects of oral, transdermal (patch and gel), intranasal, sublingual, buccal, vaginal, subcutaneous and intramuscular administration of estrogens, as well as of oral, vaginal, transdermal, intranasal, buccal, intramuscular and intrauterine application of progestogens are discussed. The various types of progestogens, their receptor interaction, hormonal pattern and the hormonal activity of certain metabolites are described in detail. The structural formulae, serum concentrations, binding affinities to steroid receptors and serum binding globulins, and the relative potencies of the available estrogens and progestins are presented. Differences
in the tissue-specific effects of the various compounds and regimens and their potential implications with the risks and benefits of hormone replacement therapy are discussed.
One member you may want to contact is KayXO. She is very knowledgeable about these things, and her E2 levels are astronomical, compared to most girls.
With kindness,
Terri